Glicazide
Chemical
Sulphonylurea
Use
- T2DM
Presentation
Tablets
Dose
40-160mg daily
Route
PO
Onset
2-8hrs
DoA
10-24h
MoA
Bind sulphonylurea receptor of b-cells in pancreas
Close KATP channels
Depolarises b -cell
Ca++ influx
Exocytosis of insulin containing vesicles
Increase peripheral [insulin]
Pre-requisite of adequate b-cells function
PD
Improves insulin dynamics
PK
A
Rapid & good absorption
D
PPB 94%
M
Extensively in liver. Oxidised & hydroxylated derivatives, glucuronic acid conjugates
E
Metabolites in urine & faeces
Adverse Effects
Hypoglycaemia in starved state – must be stopped preop
Weight gain
GI disturbances
Contraindicated
Elderly
Renal impairment
Fasting